Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Winrevair
Pharma
ICER, West Health call out excessive U.S. drug launch prices
From a starting rate of $190,000 in 2022, the median net launch price of U.S. drugs jumped up 35% by 2025, a new ICER and West Health report claims.
Fraiser Kansteiner
Oct 21, 2026 10:36am
Merck reports mixed results in Q1 for Winrevair, Ohtuvayre
Apr 30, 2026 11:40am
Merck set to advance Winrevair to phase 3 in new indication
Nov 18, 2025 11:22am
Merck nabs updated FDA label for PAH med Winrevair
Oct 27, 2025 11:37am
Merck releases results from successful trial of Winrevair
Sep 30, 2025 8:00am
Merck's Winrevair cuts death, morbidity risk by 76%
Mar 31, 2025 10:00am
